French Biotech Stocks

Sanofi

Market Cap: €100.2b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Eurofins Scientific

Market Cap: €11.0b

Provides various analytical testing and laboratory services worldwide.

Ipsen

Market Cap: €9.5b

A biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide.

Virbac

Market Cap: €3.0b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific.

Vetoquinol

Market Cap: €995.6m

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.

Valneva

Market Cap: €655.1m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

DBV Technologies

Market Cap: €655.0m

A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.

Boiron

Market Cap: €522.6m

Manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.

Cellectis

Market Cap: €304.9m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.

Genfit

Market Cap: €261.4m

A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.

Eurobio Scientific Société anonyme

Market Cap: €243.1m

Engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and oncology.

Euroapi

Market Cap: €209.5m

Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally.

Innate Pharma

Market Cap: €149.0m

Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.

OSE Immunotherapeutics

Market Cap: €118.8m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

Oncodesign Société Anonyme

Market Cap: €99.4m

Oncodesign Société Anonyme, a biopharmaceutical company, conducts research and development work on new therapeutic and diagnostic tools with pharmaceutical firms, biotech companies, public research institutions, and investment groups.

MaaT Pharma

Market Cap: €89.9m

A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.

Eurofins-Cerep

Market Cap: €89.8m

Provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally.

Novacyt

Market Cap: €29.6m

Develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors.

Aelis Farma

Market Cap: €15.8m

A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.

Pherecydes Pharma Société anonyme

Market Cap: €14.4m

Pherecydes Pharma Société anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages.

Poxel

Market Cap: €12.4m

A clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases.

Oncodesign Precision Medicine Société anonyme

Market Cap: €7.1m

A biopharmaceutical company, engages in the precision medicine business.

IntegraGen

Market Cap: €893.8k

Provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France.

Neovacs

Market Cap: €4.2k

A biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France.